Follow Us
© 2026 Arizent. All rights reserved.
Verily, the Alphabet life sciences unit that’s previously targeted mosquito-borne illness and launched COVID-19 testing programs, is getting into the health insurance business.
On Tuesday, the San Francisco Bay Area company announced a new subsidiary named Coefficient Insurance that will also be backed by the commercial insurance unit of Swiss Re Group.
For reprint and licensing requests for this article, click here.
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.
To truly flip the script on metabolic disease, benefit leaders must build a cost-efficient, supportive plan for employees and their business.
Providing better access to primary care providers is key to cutting down on workers' serious medical conditions and encouraging a better quality of life.
As more Americans turn to GLP-1 medications for weight loss, employers are weighing the benefits of coverage against rising healthcare expenses and long-term costs.
Only 14% of workers let managers know they're struggling, according to a Headspace report, highlighting a missed opportunity for intervention.
